Predictors of mortality in patients with severe COVID-19 pneumonia—a retrospective study
A Nuchin, R Kumar, PA Mahesh - Advances in respiratory medicine, 2021 - mdpi.com
… data on mortality predictors in severe COVID-19 pneumonia patients admitted to ICU in the
… in patients with severe COVID-19 pneumonia admitted to a tertiary care COVID-19 hospital …
… in patients with severe COVID-19 pneumonia admitted to a tertiary care COVID-19 hospital …
The clinical and chest CT features associated with severe and critical COVID-19 pneumonia
K Li, J Wu, F Wu, D Guo, L Chen, Z Fang… - Investigative …, 2020 - journals.lww.com
… associated with severe/critical COVID-19 pneumonia by comparing severe/critical patients
with ordinary patients. In this study, we found that the severe/critical patients were older and …
with ordinary patients. In this study, we found that the severe/critical patients were older and …
Tocilizumab in hospitalized patients with severe Covid-19 pneumonia
IO Rosas, N Bräu, M Waters, RC Go… - … England Journal of …, 2021 - Mass Medical Soc
… In this phase 3 trial, we randomly assigned patients who were hospitalized with severe
Covid-19 pneumonia in a 2:1 ratio receive a single intravenous infusion of tocilizumab (at a dose …
Covid-19 pneumonia in a 2:1 ratio receive a single intravenous infusion of tocilizumab (at a dose …
Severe covid-19 pneumonia: pathogenesis and clinical management
AH Attaway, RG Scheraga, A Bhimraj, M Biehl… - bmj, 2021 - bmj.com
… and clinical features of covid-19, the … of patients with covid-19 pneumonia. The review
is aimed at clinicians and intensivists caring for patients with severe covid-19 pneumonia as …
is aimed at clinicians and intensivists caring for patients with severe covid-19 pneumonia as …
Respiratory follow-up of patients with COVID-19 pneumonia
… We recommend that patients cared for in ICU or those with severe COVID-19 pneumonia
(box 2) should undergo an early follow-up assessment at 4–6 weeks after discharge. …
(box 2) should undergo an early follow-up assessment at 4–6 weeks after discharge. …
Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China
Y Wang, W Jiang, Q He, C Wang, B Liu, P Zhou… - MedRxiv, 2020 - medrxiv.org
… A total of 46 hospitalized patients with severe COVID-19 pneumonia were diagnosed
and included in this study, the age, sex, comorbidities, clinical and laboratory parameters on …
and included in this study, the age, sex, comorbidities, clinical and laboratory parameters on …
[HTML][HTML] Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the UK POETIC survey
J Melhorn, A Achaiah, FM Conway… - European …, 2022 - Eur Respiratory Soc
… understanding that coronavirus disease 2019 (COVID-19) is … incidence among patients
hospitalised with COVID-19 in the … patients had severe acute respiratory syndrome coronavirus …
hospitalised with COVID-19 in the … patients had severe acute respiratory syndrome coronavirus …
Pulmonary embolism in patients with COVID-19 pneumonia
F Bompard, H Monnier, I Saab… - European …, 2020 - Eur Respiratory Soc
… of the COVID-19 pneumonia patients evaluated after contrast administration had acute PE on
… patients with COVID-19 pneumonia, particularly in those with marked elevation of D-dimer. …
… patients with COVID-19 pneumonia, particularly in those with marked elevation of D-dimer. …
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia
… patients with severe COVID-19 infection [5]. The rationale for prolonged, low-dose corticosteroid
treatment in severe COVID-19 … hypoxemic patients with severe SARS-CoV-2 pneumonia …
treatment in severe COVID-19 … hypoxemic patients with severe SARS-CoV-2 pneumonia …
Development of bullous lung disease in a patient with severe COVID-19 pneumonitis
S Berhane, A Tabor, A Sahu, A Singh… - BMJ Case Reports …, 2020 - casereports.bmj.com
… acute chronic inflammation with no malignant cells nor other abnormalities. In summary, other
than severe COVID-19, … with severe COVID-19 pneumonitis, the patient underwent 8 days …
than severe COVID-19, … with severe COVID-19 pneumonitis, the patient underwent 8 days …
相关搜索
- severe covid 19 pneumonia nonintubated patients
- severe covid 19 pneumonia hospitalized patients
- clinical severity of covid 19 pneumonia
- patients with severe covid 19 disease
- poetic survey severe covid 19 pneumonitis
- corticosteroid treatment non-severe covid 19 pneumonia
- severe covid 19 pneumonia methylprednisolone pulses
- severe covid 19 pneumonia low dose
- efficacy evaluation non-severe covid 19 pneumonia
- severe covid 19 pneumonia retrospective study
- severe and critical covid 19 pneumonia
- covid 19 pneumonia patient risk factors
- severe covid 19 mortality of patients
- covid 19 pneumonia tocilizumab in patients
- covid 19 pneumonia pneumomediastinum in patients
- post-acute covid 19 syndrome